Znaleziono wyników: 5

Liczba wyników na stronie

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: ovarian carcinoma

Sortuj według:

Ogranicz wyniki do:

Relationships between immunologically distinct P53 forms and P21 WAF1 and PCNA expression in ovarian carcinomas

100%

Harlozinska A., Bar J., Montenarh M., Kartarius S.

Cellular and Molecular Biology Letters

2002

tom 07

nr Suppl.

A characterization of the temperature-sensitivity of an ovarian carcinoma cell line [OvBH-1], independent of p53 status

88%

Bar J. K., Harlozinska A., Wyrodek W., Kartarius S., Montenarh M., Rodriguez-Parkitna J. M., Kochman M., Ozyhar A.

Cellular and Molecular Biology Letters

2002

tom 07

nr Suppl.

The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma

75%

Haczynska H., Gerber J., Osada J., Warwas M.

Acta Biochimica Polonica

1997

tom 44

nr 1

Ovarian carcinomas exhibited a higher cathepsin B activity than did normal ovaries. The plasma membrane fractions of ovarian cancers were enriched in the activities of both cathepsin and cysteine proteinase inhibitors. The ratio of cathepsin to the inhibitors in these fractions was higher at stage IV than at stage III of the disease, classified according to the Federation of International Gynecology and Obstetrics.

The effect of wortmannin and promoting phorbol ester [TPA] on migration of ovary carcinoma cells

63%

Miloszewska J., Szaniawska B., Kowalczyk D., Janik P.

Cellular and Molecular Biology Letters

1999

tom 04

nr 2

The purpose of the present study was to determine the role of PI 3 kinase in tumor cell migration. The migration of ovary carcinoma cells (OVP10) was strongly inhibited by wortmannin to the same extent as by TPA treatment. The strongest additive inhibitory effect was noted after cell treatment with wortmannin and TPA together. Western blotting studies showed activation / partial down regulation of PKC after TPA treatment and decreased amount of the enzyme following wortmannin exposure. Altogether, it looks like wortmannin inhibits migration of studied cells.

Chemioterapia dootrzewnowa w raku jajnika

51%

Emerich J., Dudziak M.

Acta Biologica et Medica

1992

tom 18

95-102

Ograniczanie wyników

3 Cellular and Molecular Biology Letters

1 Acta Biochimica Polonica

1 Acta Biologica et Medica

2 Harlozinska A.

2 Kartarius S.

2 Montenarh M.

1 Bar J.

1 Bar J. K.

1 Dudziak M.

1 Emerich J.

1 Gerber J.

1 Haczynska H.

1 Janik P.

1 Kochman M.

1 Kowalczyk D.

1 Miloszewska J.

1 Osada J.

1 Ozyhar A.

1 Rodriguez-Parkitna J. M.

1 Szaniawska B.

1 Warwas M.

1 Wyrodek W.

2 2002

1 1999

1 1997

1 1992

Wyniki wyszukiwania

Relationships between immunologically distinct P53 forms and P21 WAF1 and PCNA expression in ovarian carcinomas

A characterization of the temperature-sensitivity of an ovarian carcinoma cell line [OvBH-1], independent of p53 status

The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma

The effect of wortmannin and promoting phorbol ester [TPA] on migration of ovary carcinoma cells

Chemioterapia dootrzewnowa w raku jajnika